Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 1094

NOTICE by Amgen Inc. re #1093 MOTION for Leave to File Amgen's Reply in Further Support of Its Motion in Limine No. 13: to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery of Service of Confidential Document (Gottfried, Michael)

Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Doc. 1094

Case 1:05-cv-12237-WGY

Document 1094

Filed 09/20/2007

Page 1 of 3

UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS ____________________________________ ) AMGEN INC., ) ) Plaintiff, ) ) C.A. NO.: 05-12237-WGY v. ) ) F. HOFFMANN-LAROCHE ) LTD., a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN LAROCHE ) INC., a New Jersey Corporation, ) ) Defendants. ) ____________________________________) NOTICE OF SERVICE OF CONFIDENTIAL DOCUMENT TO BE FILED IN CONNECTION WITH AMGEN INC.'S MOTION FOR LEAVE TO REPLY IN FURTHER SUPPORT OF ITS MOTION IN LIMINE NO. 13 TO EXCLUDE EVIDENCE AND ARGUMENT REGARDING ROCHE'S FDA FILINGS AND COMMUNICATIONS WITHHELD THROUGHOUT FACT DISCOVERY The Plaintiff, Amgen Inc. ("Amgen"), hereby certifies, pursuant to the Protective Order dated February 7, 2007 [Docket No. 274], that it served today, via hand-delivery, upon defense counsels at Bromberg & Sunstein LLP and at Kaye Scholer LLP, the following: · Confidential Exhibit 1 to the [Proposed] Declaration Of Aaron R. Hand in Support of Amgen Inc.'s Reply in Further Support of Its Motion in Limine No. 13 to Exclude Evidence and Argument Regarding Roche's FDA Filings and Communications Withheld Throughout Fact Discovery

This document contains information designated as confidential by the defendants ("Roche"). Accordingly, pursuant to paragraph 14 of the Protective Order, Roche has four (4) Court days to seek leave of Court pursuant to Local Rule 7.2 if they seek to have the Court deem the document confidential.

DM1\1196809.1

Dockets.Justia.com

Case 1:05-cv-12237-WGY

Document 1094

Filed 09/20/2007

Page 2 of 3

Dated: September 20, 2007

Respectfully Submitted, AMGEN INC., By its attorneys,

Of Counsel: Stuart L. Watt Wendy A. Whiteford Monique L. Cordray Darrell G. Dotson Kimberlin L. Morley Erica S. Olson AMGEN INC. One Amgen Center Drive Thousand Oaks, CA 91320-1789 [phone]

/s/ Michael R. Gottfried D. Dennis Allegretti (BBO#545511) Michael R. Gottfried (BBO# 542156) Patricia R. Rich (BBO# 640578) DUANE MORRIS LLP 470 Atlantic Avenue, Suite 500 Boston, MA 02210 Telephone: [phone] Facsimile: [phone] Lloyd R. Day, Jr. (pro hac vice) DAY CASEBEER, MADRID & BATCHELDER LLP 20300 Stevens Creek Boulevard, Suite 400 Cupertino, CA 95014 Telephone: [phone] Facsimile: [phone] William Gaede III (pro hac vice) McDERMOTT WILL & EMERY 3150 Porter Drive Palo Alto, CA 94304 Telephone: [phone] Facsimile: [phone] Kevin M. Flowers(pro hac vice) MARSHALL, GERSTEIN & BORUN LLP 233 South Wacker Drive 6300 Sears Tower Chicago, IL 60606 Telephone: [phone] Facsimile: [phone]

2
DM1\1196809.1

Case 1:05-cv-12237-WGY

Document 1094

Filed 09/20/2007

Page 3 of 3

CERTIFICATE OF SERVICE I hereby certify that this document, filed through the ECF system will be sent electronically to the registered participants as identified on the Notice of electronic filing and paper copies will be sent to those indicated as non-registered participants. /s/ Michael R. Gottfried Michael R. Gottfried

3
DM1\1196809.1